Triple combination therapy for hepatitis c with telaprevir exhibits greater early antiviral suppression than with boceprevir regardless hiv status
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Data de publicación
2013Título da revista
JOURNAL OF HEPATOLOGY
Tipo de contido
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)